| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9283217 | Microbes and Infection | 2005 | 8 Pages |
Abstract
New vaccine candidates exploiting the rational combination of regulatory and structural HIV gene products are being developed within the program of the AIDS Vaccine Integrated Project (AVIP) and will be tested in comparative preclinical and clinical trials with the ultimate goal of selecting proper candidates for advanced clinical testing in developing countries.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Barbara Ensoli,